CN1186492A - 咪唑并[1,2－α]吡啶衍生物 - Google Patents

咪唑并[1,2－α]吡啶衍生物 Download PDF

Info

Publication number
CN1186492A
CN1186492A CN96194403A CN96194403A CN1186492A CN 1186492 A CN1186492 A CN 1186492A CN 96194403 A CN96194403 A CN 96194403A CN 96194403 A CN96194403 A CN 96194403A CN 1186492 A CN1186492 A CN 1186492A
Authority
CN
China
Prior art keywords
compound
formula
represent
alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96194403A
Other languages
English (en)
Chinese (zh)
Inventor
P·J·贝斯威克
I·B·坎贝尔
A·内勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9506965.4A external-priority patent/GB9506965D0/en
Priority claimed from GBGB9512099.4A external-priority patent/GB9512099D0/en
Priority claimed from GBGB9516117.0A external-priority patent/GB9516117D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN1186492A publication Critical patent/CN1186492A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN96194403A 1995-04-04 1996-04-02 咪唑并[1,2－α]吡啶衍生物 Pending CN1186492A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9506965.4A GB9506965D0 (en) 1995-04-04 1995-04-04 Chemical compounds
GB9506965.4 1995-04-04
GBGB9512099.4A GB9512099D0 (en) 1995-06-14 1995-06-14 Chemical compounds
GB9512099.4 1995-06-14
GBGB9516117.0A GB9516117D0 (en) 1995-08-05 1995-08-05 Chemical compounds
GB9516117.0 1995-08-05

Publications (1)

Publication Number Publication Date
CN1186492A true CN1186492A (zh) 1998-07-01

Family

ID=27267657

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96194403A Pending CN1186492A (zh) 1995-04-04 1996-04-02 咪唑并[1,2－α]吡啶衍生物

Country Status (17)

Country Link
EP (1) EP0819127A1 (is)
JP (1) JPH11501049A (is)
KR (1) KR19980703559A (is)
CN (1) CN1186492A (is)
AU (1) AU5276696A (is)
BG (1) BG101934A (is)
CA (1) CA2216809A1 (is)
CZ (1) CZ313397A3 (is)
EA (1) EA199700209A1 (is)
HU (1) HUP9801602A3 (is)
IS (1) IS4570A (is)
NO (1) NO974595L (is)
NZ (1) NZ304886A (is)
PL (1) PL322623A1 (is)
SK (1) SK133297A3 (is)
TR (1) TR199701105T1 (is)
WO (1) WO1996031509A1 (is)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632578B2 (en) 2003-02-07 2009-12-15 Samsung Mobile Display Co., Ltd. Emitting compound for organic electroluminescent device and organic electroluminescent device using the same

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764292B1 (fr) * 1997-06-10 2000-12-29 Innothera Lab Sa Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
EP1510519B1 (en) 1997-09-05 2006-02-15 Glaxo Group Limited Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives
FR2770131A1 (fr) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
FR2771005B1 (fr) * 1997-11-18 2002-06-07 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
GB9810920D0 (en) * 1998-05-21 1998-07-22 Merck Sharp & Dohme Therapeutic use
ES2140354B1 (es) 1998-08-03 2000-11-01 S A L V A T Lab Sa Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2.
TW587079B (en) 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
TR200101208T2 (tr) * 1998-11-03 2001-10-22 Glaxo Group Limited Seçici COX-2 inhibitörleri olarak pirazolopiridin türevleri
ATE261444T1 (de) * 1999-02-27 2004-03-15 Glaxo Group Ltd Pyrazolopyridine
GB9930358D0 (en) 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
RU2002119574A (ru) 1999-12-23 2004-01-10 Нитромед, Инк. (Us) Нитрозированные и нитрозилированные ингибиторы циклооксигеназы-2, композиции на их основе и способы их применения
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
PE20011333A1 (es) 2000-03-16 2002-01-16 Almirall Prodesfarma Ag Derivados de 2-fenilpiran-4-ona como inhibidores de ciclooxigenasa 2
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
CA2415577C (en) 2000-07-20 2010-10-19 Lauras As Use of cox-2 inhibitors for preventing immunodeficiency
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0025449D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
ATE300541T1 (de) 2000-12-15 2005-08-15 Glaxo Group Ltd Pyrazolopyridinderivate
AU2002239344A1 (en) 2000-12-15 2002-06-24 Glaxo Group Limited Pyrazolopyridines
US7153855B2 (en) 2001-03-08 2006-12-26 Smithkline Beecham Corporation Pyrazolopyridinyl pyrimidine therapeutic compounds
US7034030B2 (en) 2001-03-30 2006-04-25 Smithkline Beecham Corporation Pyralopyridines, process for their preparation and use as therapeutic compounds
PE20021017A1 (es) 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible
JP4219171B2 (ja) 2001-04-10 2009-02-04 スミスクライン ビーチャム コーポレーション 抗ウイルス性ピラゾロピリジン化合物
ATE296826T1 (de) 2001-04-27 2005-06-15 Smithkline Beecham Corp Pyrazolo(1,5)pyridinderivate
US6756498B2 (en) 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
EP1401836B1 (en) 2001-06-21 2006-08-23 SmithKline Beecham Corporation Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP2005508955A (ja) 2001-10-05 2005-04-07 スミスクライン ビーチャム コーポレーション ヘルペスウイルス感染の治療で使用されるためのイミダゾ−ピリジン誘導体
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124939D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
US7199120B2 (en) 2001-12-11 2007-04-03 Smithkline Beecham Corporation Pyrazolo-pyridine derivatives as antiherpes agents
NZ533865A (en) 2002-02-12 2006-02-24 Smithkline Beecham Corp Nicotinamide derivates useful as p38 inhibitors
EP1539679A4 (en) 2002-06-28 2007-07-04 Nitromed Inc OXIM- AND / OR HYDRAZO-CONTAINING, NITROSED AND / OR NITROSYLATED CYCLOOXIGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND USE METHODS
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
JP2006504728A (ja) 2002-10-03 2006-02-09 スミスクライン ビーチャム コーポレーション ピラソロピリジン誘導体系治療用化合物
GB0308185D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308186D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308201D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
WO2004098619A2 (en) 2003-05-07 2004-11-18 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
GB0318814D0 (en) 2003-08-11 2003-09-10 Smithkline Beecham Corp Novel compounds
US8067464B2 (en) 2004-10-04 2011-11-29 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
WO2007016677A2 (en) 2005-08-02 2007-02-08 Nitromed, Inc. Nitric oxide enhancing antimicrobial compounds, compositions and methods of use
EP2007705A4 (en) 2006-03-29 2011-09-07 Nicox Sa NITROGEN MONOXIDE REINFORCING PROSTAGLANDIN COMPOUNDS, COMPOSITION AND APPLICATION PROCESS
WO2008058126A2 (en) 2006-11-06 2008-05-15 Supergen, Inc. Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
WO2013013188A1 (en) 2011-07-21 2013-01-24 Tolero Pharmaceuticals, Inc. Heterocyclic protein kinase inhibitors
EP3292213A1 (en) 2015-05-04 2018-03-14 Academisch Medisch Centrum Biomarkers for the detection of aspirin insensitivity
EP3924351A4 (en) 2019-02-12 2022-12-21 Sumitomo Pharma Oncology, Inc. FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632578B2 (en) 2003-02-07 2009-12-15 Samsung Mobile Display Co., Ltd. Emitting compound for organic electroluminescent device and organic electroluminescent device using the same

Also Published As

Publication number Publication date
JPH11501049A (ja) 1999-01-26
HUP9801602A2 (hu) 1998-11-30
AU5276696A (en) 1996-10-23
HUP9801602A3 (en) 1999-01-28
EA199700209A1 (ru) 1998-04-30
CZ313397A3 (cs) 1998-03-18
MX9707379A (es) 1997-11-29
TR199701105T1 (xx) 1998-02-21
CA2216809A1 (en) 1996-10-10
BG101934A (en) 1999-04-30
SK133297A3 (en) 1998-07-08
WO1996031509A1 (en) 1996-10-10
NO974595D0 (no) 1997-10-03
KR19980703559A (ko) 1998-11-05
PL322623A1 (en) 1998-02-02
EP0819127A1 (en) 1998-01-21
NZ304886A (en) 1998-11-25
NO974595L (no) 1997-12-03
IS4570A (is) 1997-09-25

Similar Documents

Publication Publication Date Title
CN1186492A (zh) 咪唑并[1,2－α]吡啶衍生物
CN1332741A (zh) 作为选择性cox－2抑制剂的吡唑并吡啶衍生物
CN1138774C (zh) 取代的6,6-杂-双环衍生物
CN1187330C (zh) 吲哚衍生物、制备它们的方法、含有它们的药用组合物和它们的医疗应用
CN1310917C (zh) 趋化因子受体活性的四氢吡喃基环戊基四氢吡啶并吡啶调节剂
EP2958915B1 (en) Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
CN1227552A (zh) 含有取代的吡啶并或嘧啶并的6,6－或6,7－二环衍生物
CN1155281A (zh) 新的嘧啶衍生物及其制备方法
CN101052618A (zh) 用作治疗阿尔茨海默氏病的β－分泌酶抑制剂的2－氨基吡啶化合物
CN1259951A (zh) 新化合物
CN1314904A (zh) 用作抗癌剂的炔基取代的喹啉－2－酮衍生物
JP6506833B2 (ja) イミダゾピリダジン化合物
CN1227554A (zh) 取代的6,5－杂二环衍生物
CN1483034A (zh) 吲哚衍生物及其作为5-ht2b和5-ht2c受体配体的应用
CN1446217A (zh) 用作磷酸二酯酶抑制剂的β－咔啉衍生物
CN1223651A (zh) 取代的吲哚衍生物以及它们作为iv型磷酸二酯酶(pde)和肿瘤坏死因子(tnf)抑制剂的用途
CN1331076A (zh) 稠合的吡唑基化合物、包含该化合物的组合物及该化合物的应用
CN1344257A (zh) cGMP磷酸二酯酶的稠合吡啶并哒嗪抑制剂
CN86104539A (zh) 羟基和烷氧基嘧啶类
CN1399633A (zh) 嘧啶衍生物
CN1871242A (zh) 作为mch r1拮抗剂用于治疗肥胖症、糖尿病、抑郁症和焦虑的3－(4－(氨基苯基)噻吩并嘧啶－4－酮衍生物
JP2021527660A (ja) ＲＯＲγｔのモジュレータとしてのフェニル及びピリジニル置換イミダゾール
CN1882585A (zh) 羟烷基取代的吡啶并－7－嘧啶－7－酮
CN1094406A (zh) 用于治疗人体识别障碍的3，3′-二取代的-1，3-二氢-2H-吡咯[2，3-b]杂环-2-酮
CN101054380A (zh) 用作细胞周期依赖性蛋白激酶抑制剂的吡唑并嘧啶类衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1009450

Country of ref document: HK